Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭

I have DLBC Lymphoma. Have had 6 R Chop treatments and multiple Pet Scans. Can anyone share their pros and cons of Car T Cell treatments? As this may be an optional treatment since my mass is shrinking however still appearing “Bright” in my last Pet Scan which my Oncologist isn’t pleased with. Any and all feedback will be appreciated. 😄

July 9
 · 
Be the first to react
MyLymphomaTeam

It's great that your mass is shrinking — that's real progress! It's completely understandable to want to learn more about CAR T-cell therapy as a possible next step with DLBCL.

Here's a plain-language breakdown of how it works:

- Your T cells (immune cells) are collected from your blood
- They're sent to a lab and Show Full Answer

It's great that your mass is shrinking — that's real progress! It's completely understandable to want to learn more about CAR T-cell therapy as a possible next step with DLBCL.

Here's a plain-language breakdown of how it works:

- Your T cells (immune cells) are collected from your blood
- They're sent to a lab and engineered to recognize and attack lymphoma cells
- A short course of low-dose chemotherapy is given to prepare your body
- The modified CAR T cells are infused back into your bloodstream to find and destroy cancer cells
- The cells can keep working for weeks or even months after infusion For DLBCL specifically, there are FDA-approved CAR T-cell therapies available:

- Axicabtagene ciloleucel (Yescarta)
- Lisocabtagene maraleucel (Breyanzi)
- Tisagenlecleucel (Kymriah)

These are typically used when lymphoma hasn't responded well to other treatments or has come back after treatment. Like any treatment, there are important potential side effects to be aware of:

- Cytokine release syndrome — a serious immune reaction
- Neurological effects — such as confusion or seizures
- Increased infection risk — due to a weakened immune system
- Low blood counts and fatigue

Because of these risks, CAR T-cell therapy is typically offered after at least two other treatments have been tried. The good news is that CAR T-cell therapy has shown strong results in clinical trials and real-world studies, even for people with high-risk DLBCL. It has genuinely expanded options for people who previously had very limited choices.

That said, your oncologist is the best person to guide whether this is the right path for you right now, especially given where things stand after your R-CHOP treatments. It's worth having a detailed conversation with them about eligibility and timing. 💪

July 9

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Napa, CA

A MyLymphomaTeam Member asked a question 💭
Moorestown, NJ